- -

Nrf2 as a therapeutic target for rheumatic diseases

RiuNet: Institutional repository of the Polithecnic University of Valencia

Share/Send to

Cited by


  • Estadisticas de Uso

Nrf2 as a therapeutic target for rheumatic diseases

Show full item record

Ferrandiz Manglano, ML.; Nacher-Juan, J.; Alcaraz Tormo, MJ. (2018). Nrf2 as a therapeutic target for rheumatic diseases. Biochemical Pharmacology. 152:338-346. https://doi.org/10.1016/j.bcp.2018.04.010

Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10251/141951

Files in this item

Item Metadata

Title: Nrf2 as a therapeutic target for rheumatic diseases
Author: Ferrandiz Manglano, Mª Luisa Nacher-Juan, Josep Alcaraz Tormo, Mª Jose
Issued date:
[EN] Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is a master regulator of cellular protective processes. Rheumatic diseases are chronic conditions characterized by inflammation, pain, tissue damage and limitations ...[+]
Subjects: Nrf2,Rheumatic conditions , Rheumatoid arthritis , Systemic lupus erythematosus , Osteoarthritis , Osteoporosis
Copyrigths: Reconocimiento - No comercial - Sin obra derivada (by-nc-nd)
Biochemical Pharmacology. (issn: 0006-2952 )
DOI: 10.1016/j.bcp.2018.04.010
Publisher version: http://doi.org/10.1016/j.bcp.2018.04.010
Project ID:
info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016/SAF2017-85806-R/ES/MECANISMOS REGULADORES DE LA INFLAMACION Y SU RESOLUCION EN ENFERMEDADES CRONICAS ARTICULARES Y DE LA PIEL/
This work has been funded by grant SAF2017-85806-R (MINECO, FEDER, Spain).
Type: Artículo



This item appears in the following Collection(s)

Show full item record